相关实验视频

Updated: May 30, 2025

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

通过设计的质量方法来开发abemaciclib固体脂质纳米颗粒,以准乳腺癌细胞系

Bonnie Chin¹, Wei Meng Lim², Samah Hamed Almurisi^3,4

¹School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.

Therapeutic delivery

|January 29, 2025

概括

装有abemaciclib的固体脂质纳米颗粒 (ABE-SLNs) 是使用Quality-by-Design开发的. 这些纳米粒子增强抗癌药物的溶解性,细胞吸收和细胞毒性,提供了一个有前途的新输送系统.

科学领域:

纳米技术纳米技术
制药科学制药科学
在瘤学瘤学.

背景情况:

阿贝马西克利布 (ABE) 面临着低生物可用性和多药耐药性的挑战.
有效的输送系统对于提高抗癌药物疗效至关重要.

研究的目的:

为了开发带有Abemaciclib的固体脂质纳米粒子 (ABE-SLNs).
为了增强药物溶解性,细胞吸收,和细胞毒性Abemaciclib.
通过使用设计质量 (QbD) 原则来优化ABE-SLNs.

主要方法:

使用融乳化和超声波来制备ABE-SLN.
设计质量 (QbD) 用于配方优化.
颗粒的特征包括尺寸,PDI和泽塔潜力分析.

主要成果:

优化的ABE-SLN (Precirol-ATO5,Brij-58) 显示颗粒大小为170.4nm,PDI为0.25,和泽塔电位为-26.4mV.
在ABE-SLN中,药物释放持续,捕获效率高 (79.96%).
在MDA-MB-231和T47D细胞中观察到增强的抗癌活性;在Caco-2细胞中增加细胞吸收.

结论:

通过设计质量实现了高捕获效率和ABE-SLN的持续释放.
与自由的Abemaciclib相比,ABE-SLNs显著改善了细胞吸收和细胞毒性.
这种纳米粒子方法为癌症药物输送提供了一种新且潜在的优越方法.

关键词:

阿贝马西克利布 (Abemaciclib) 是一个女性.布里奇-58就是这样的.普雷西罗尔 (Precirol) 是一种ATO-5的药物.这是一种抗癌药物.固体脂质纳米粒子固体脂质纳米粒子

更多相关视频

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...